Brolucizumab coming soon?

Quote

anonymous

Guest
This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.
 






anonymous said:
This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.
Click to expand...

No question about it. Our GM has never sold a day in his life and is more focused on micromanaging people. Len’s arrogance will help brolucizumab greatly.
 






anonymous said:
This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.
Click to expand...

Are “renting specialists” realtors?
 


















Great drugs and pipeline. Terrible, incompetent, arrogant and toxic leadership. Lots of turnover. There is no one happy here and the morale sucks across all businesses. Primary Care metrics makes it even more specially fucked. Equity blows. Otherwise- awesome place.
 






Best wishes and thanks to Bryan and Kevin. Let’s count the recent carnage from MM: NL, BT, KR, ST, AG, BM, NM, CK, RM, MC...so many more on the way. While Novartis is getting geared up, we have a combination of a mass exodus, poor morale, and toxic culture. This while we get ready for a assimilation of new sales reps, new indication, and new competitor. Should kick some ass with a new primary care leader with no Ophthalmology experience. Strong! Protect this culture.
 






Get ready for the message certifications with your DM at meetings and over the phone, calls per day and all the micromanaging BS culture that comes from it, Eylea. You will be expected to close the customer hard. You will be asked to be bold. Your customers do not know anything. You need to be "clinically disruptive". You guys are going to have so much fun. PW will suck the life out of you. She was at one Praluent meeting and she single handedly destroyed the moral of the entire sales force (as if things could not get any worse). Knows nothing but acts like she does. Not the brightest cookie in the cookie jar. Just what we needed, someone to run Eylea into the ground as if it needs help with the competition on the horizon. Good luck.
 












anonymous said:
Get ready for the message certifications with your DM at meetings and over the phone, calls per day and all the micromanaging BS culture that comes from it, Eylea. You will be expected to close the customer hard. You will be asked to be bold. Your customers do not know anything. You need to be "clinically disruptive". You guys are going to have so much fun. PW will suck the life out of you. She was at one Praluent meeting and she single handedly destroyed the moral of the entire sales force (as if things could not get any worse). Knows nothing but acts like she does. Not the brightest cookie in the cookie jar. Just what we needed, someone to run Eylea into the ground as if it needs help with the competition on the horizon. Good luck.
Click to expand...

Who promoted her? She did nothing in Praluent except lower morale.
 












anonymous said:
This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.
Click to expand...
Makes sense that the company is focusing on DME and has formed new team. Physicians believe we will lose most of Wet AMD business to bro
 












Top Bottom
Back
Quote